The Value of In Vitro Binding as Predictor of In Vivo Results: A Case for [18F]FDDNP PET
作者:Graham B. Cole、Nagichettiar Satyamurthy、Jie Liu、Koon-Pong Wong、Gary W. Small、Sung-Cheng Huang、Janez Košmrlj、Jorge R. Barrio、Andrej Petrič
DOI:10.1007/s11307-018-1210-2
日期:2019.2
demonstrate the critical importance of rigorous experimental design for meaningful in vitro determinations. [18F]FDDNP binding to both amyloid plaques and neurofibrillary tangles was confirmed by amyloid and tau immunohistochemical stains of adjacent tissues. ConclusionsThis work illustrates the sensitivity of in vitro techniques to various experimental conditions and underscores that conclusions obtained
目的当用used标记的生物标志物的体外结果被人为地批评体内数据和用正电子发射体和正电子发射断层显像(PET)标记的相同示踪剂得出的结论时,必须谨慎。本文通过PET [ 18 F] FDDNP的使用来说明这一概念,该[ 18 F] FDDNP是一种用于体内可视化人类β-淀粉样蛋白和tau蛋白神经聚集体的生物标记物,后来与[ 3 H] FDDNP报道的体外数据相矛盾。在这项调查中,我们分析了[ 3 H] FDDNP体外实验设计中涉及的多个因素 导致错误解释结果的研究。 程序本工作描述了[ 3 H] FDDNP的合成,表征,纯度和放射稳定性的动力学的全部细节。还介绍了使用[ 18 F] FDDNP和[ 3 H] FDDNP进行宏观和微观放射自显影检测tau和β-淀粉样蛋白聚集体的最佳体外条件。宏观放射自显影法的测定是使用先前文献中所述的既定方法,用已验证纯度的[ 3 H] FDDNP进行。 结果